Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postinflammatory hyperpigmentation: evolving combination treatment strategies.

Susan C Taylor1, Cheryl M Burgess, Valerie D Callender

  • 1Skin of Color Center, St. Luke's-Roosevelt Hospital Center, New York, New York, USA.

Cutis
|September 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ChatGPT Exhibits Reduced Sensitivity in Identifying Concern for Malignancy in Darker Skin Tones.

Journal of drugs in dermatology : JDD·2026
Same author

Racial Differences in Secondary Skin Complications and Timing of Topical Therapy Initiation for Pseudofolliculitis Barbae: A Multicenter Retrospective Database Cohort Study.

Journal of drugs in dermatology : JDD·2026
Same author

Adalimumab Biosimilars and Access Barriers in Dermatology.

Journal of the American Academy of Dermatology·2026
Same author

Autoimmune Disease in Central Centrifugal Cicatricial Alopecia: A Multi-Institutional Cross-Sectional Study.

Journal of the American Academy of Dermatology·2026
Same author

Postmarketing safety of bimekizumab for hidradenitis suppurativa: An early pharmacovigilance analysis using the United States Food and Drug Administration Adverse Event Reporting System.

JAAD international·2026
Same author

Perioperative racial disparities in patients with acral lentiginous melanoma undergoing Mohs micrographic surgery: A single-institution retrospective cohort study.

Journal of the American Academy of Dermatology·2026
Same journal

A Solitary Axillary Subcutaneous Mass.

Cutis·2026
Same journal

Microcystic Adnexal Carcinoma-like Neoplasm in a Patient With POT1 Mutation.

Cutis·2026
Same journal

A Hybrid Suture Technique: Suture Modification With Dental Roll Insertion.

Cutis·2026
Same journal

Beyond Conventional Paradigms: Rethinking the Evaluation and Management of Melasma.

Cutis·2026
Same journal

Social Drivers of Health Curriculum for Dermatology Residents: the UCSF Experience.

Cutis·2026
Same journal

Hospital Dermatology: Review of Research in 2024-2025.

Cutis·2026
See all related articles

Postinflammatory hyperpigmentation (PIH) is a common skin condition. Mequinol 2%-tretinoin 0.01% solution shows promise as an effective treatment for PIH.

Area of Science:

  • Dermatology
  • Cosmetic Science

Background:

  • Postinflammatory hyperpigmentation (PIH) is a prevalent condition characterized by excess pigment.
  • Untreated PIH lesions can persist, necessitating effective therapeutic interventions.

Observation:

  • Topical treatments for PIH include hydroquinone (HQ) and retinoids.
  • Newer fixed-dose combination products offer varied therapeutic options.

Findings:

  • Mequinol 2%-tretinoin (RA) 0.01% solution is identified as a potentially effective treatment for PIH.
  • Other combination therapies include HQ/retinol and FA/HQ/RA.

Implications:

  • The introduction of mequinol 2%-RA 0.01% provides a novel therapeutic avenue for managing PIH.
  • Further research may elucidate optimal treatment strategies for various PIH presentations.

Related Experiment Videos